However, pTIMP-2-loaded EVs significantly modulate MMP-2 and MMP-9 expression in these cells, highlighting their potential as biological therapeutic moieties.<h4>Conclusion</h4>Our findings suggest a rational approach for exploring EV-based gene transfer targeting MMPs in lung cancer. The gene discussed is MMP2; the disease is lung carcinoma.